Contents
Buffett’s $9.7B OxyChem Grab: The Last Power Move Before He Hands Over the KeysPrice Tag: 8× EBITDA in a Trough MarketOccidental’s Debt Cure—and Berkshire’s Hidden GainInside the Structure: Why It’s a Berkshire Win-PlusWhat Investors Should Do Now1. Watch the Chemical Cycle2. Trade the OXY Coattails3. Buy Berkshire on the Dip
